UNSPSC 51386014: Sulprosal

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 85LCU5151G. European Medicines Agency schedules Sulprosal in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10759MIG. Sulprosal generally arises in the molecular formula C10H12O6S. The term SULPROSAL is an International Non-Proprietary Name or INN. SULPROSAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

As of Q4 2014, SULPROSAL remains the US FDA Preferred Term for this commodity. Sulprosal bears US NLM identifiers UMLS ID C1883217 and NCI Concept Code C66575. SMILES: C1=CC=C(C(=C1)C(=O)OCCCS(=O)(=O)O)O.

UNSPSC 51386014 Sulprosal (Commodity) covers pharmaceutical compounds and related products procured by state and local health agencies, though the recent opportunity record shows a mismatch between the code's nominal scope and actual buying activity. Seminole County, Florida recently issued an IFB for naloxone and drug deactivation systems — products addressing opioid overdose response and controlled-substance disposal — which falls outside the sulprosal category. The county's procurement is designed to support community health initiatives, with vendors required to supply 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Bids must include all shipping and delivery costs, and vendors must meet standard compliance requirements including drug-free workplace certification, E-Verify compliance, and specified insurance coverage. The contract carries a two-year initial term with a one-year renewal option and a three-month probationary period allowing termination at county discretion.

The code shows minimal recent relevant activity. Seminole County's IFB 60459723LAS (due July 26, 2023) appears to be the only recent state or local opportunity surfaced under this code, and it addresses naloxone and drug deactivation systems rather than sulprosal itself. No other issuing bodies, geographic concentrations, or representative opportunities in the sulprosal category are evident from current procurement records. Business development professionals should verify whether this code accurately represents their product or service line — the mismatch suggests the code may not be the primary vehicle for state and local procurement in this commodity family.